© 2020 MJH Life Sciences and OncLive. All rights reserved.
May 12, 2020
Larry Anderson, MD, PhD, discusses recent advances made with novel therapies in multiple myeloma.
May 11, 2020
April 18, 2020
Larry Anderson, MD, PhD, discusses the phase II GRIFFIN trial examining the addition of daratumumab (Darzalex) to lenalidomide (Revlimid), bortezomib (Velcade), and dexamethasone (D-RVd) in patients with multiple myeloma.
January 22, 2020
Larry Anderson, MD, PhD, discusses recent FDA approvals in multiple myeloma.